Two separate passive investors (BVF and Deep Track Capital) have disclosed 5%+ stakes in FLSC within a week, signaling institutional accumulation ahead of a potential de-SPAC announcement. Monitor for a business combination target or merger vote.
Price Chart
Executive Summary
Biotechnology Value Fund (BVF) and related entities filed a Schedule 13G on October 21, 2026, disclosing aggregate beneficial ownership of 500,000 Class A ordinary shares of Frazier Life Sciences Acquisition Corp. II (FLSC), representing approximately 6.4% of shares outstanding. This is a passive stake filing with no intent to influence control, filed shortly after a similar 13G by Deep Track Capital on October 16, 2026, indicating growing institutional interest in this SPAC.
Key Financial Metrics
Key Facts
- BVF entities collectively own 500,000 Class A ordinary shares of FLSC.
- Stake represents approximately 6.4% of 7,800,000 shares outstanding (as of Oct 15, 2026).
- Filing is passive under Rule 13d-1(c) — no control intent.
- Deep Track Capital filed a separate 13G on Oct 16, 2026, also disclosing a passive stake.
- Date of event triggering filing: October 14, 2026.
Financial Impact
500,000 shares at undisclosed price; 6.4% stake in a SPAC with ~$78M trust (assuming $10/share NAV).
Risk Factors
- SPACs carry inherent risk of no suitable target found and liquidation.
- Passive filers may sell if deal terms are unfavorable.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000921895-26-002836 |
| Document: 0000921895-26-002836-index-headers.html | 0000921895-26-002836 |
| Document: 0000921895-26-002836-index.html | 0000921895-26-002836 |
| Document: 0000921895-26-002836.txt | 0000921895-26-002836 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $10.30 | awaiting T+5 | — | $10.23 (−0.68%) |
Oct 22, 2026 4d ago | SC 13G | $10.30 | awaiting T+5 | — | $10.23 (−0.68%) |
Oct 21, 2026 5d ago | SC 13D | $10.27 | awaiting T+5 | — | $10.23 (−0.39%) |
Oct 21, 2026 5d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.23 (−0.39%) |
Oct 21, 2026 5d ago | SC 13G | $10.27 | awaiting T+5 | — | $10.23 (−0.39%) |
Oct 16, 2026 11d ago | SC 13G | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.23 (−1.16%) |
Oct 15, 2026 11d ago | Insider Buy | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.23 (−1.16%) |
Oct 15, 2026 11d ago | 8-K | $10.35 $10.30 | ▼ −0.48% | ▼ −0.05% | $10.23 (−1.16%) |
Oct 14, 2026 12d ago | 424B4 | $10.49 $10.27 | ▼ −2.10% | ▼ −1.08% | $10.23 (−2.48%) |
Oct 14, 2026 13d ago | EFFECT | $10.29 $10.30 | ▲ +0.10% | ▼ −0.36% | $10.23 (−0.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers